Pfizer carries pandemic momentum into 2022, scoring another huge Paxlovid deal with the US

With two COVID-fighting antiviral pills now on tap, the U.S. government is calling for a second helping of Pfizer’s treatment.

The U.S. has doubled its order for Pfizer’s COVID-19 antiviral Paxlovid from 10 million courses to 20 million, the company said Tuesday. At the same time, the government aims to speed up the delivery of those treatments, a senior Biden administration official told Fox News.